Scott C. Bell — Endo Lab

article 2010

Neonatal administration of tamoxifen causes disruption of myometrial development but not adenomyosis in the C57/BL6J mouse

Reproduction (Cambridge, England) ·doi:10.1530/rep-09-0443

We previously demonstrated that in the CD-1 mouse, which exhibits a high incidence of age-related adenomyosis, neonatal exposure to tamoxifen induced premature uterine adenomyosis and was associated with abnormal development particularly of…

article 2000

The effect of hormone replacement therapy on the immunoreactive concentrations in the endometrium of oestrogen and progesterone receptor, heat shock protein 27, and human β-lactoglobulin

·doi:10.1093/humrep/15.1.36

We determined the expression of oestrogen receptor (ER), progesterone receptor (PR), heat shock protein 27 (HSP27) and human beta-lactoglobulin in the endometrium under hormone replacement therapy (HRT). The immunohistochemical expression d…

article 1998

Endometrial responses to hormone replacement therapy: histological features compared with those of late luteal phase endometrium

·doi:10.1093/humrep/13.6.1674

We evaluated the histological features of the endometrium in relation to the bleeding pattern in a group of women receiving oral cyclical combined hormone replacement therapy (HRT), and compared the histological features with those of lutei…

article 1990

Human 'pregnancy-associated endometrial α1-globulin', a 32 kDa insulin-like growth factor-binding protein: immunohistological distribution and localization in the adult and fetus

The Journal of endocrinology ·doi:10.1677/joe.0.1240333

We have previously shown that pregnancy-associated alpha 1-globulin, a small molecular weight (32 kDa) insulin-like growth factor-binding protein (IGF-BP), is quantitatively the major secretory protein product of the decidualized endometriu…